BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26691472)

  • 1. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients.
    Fukugaiti MH; Ignacio A; Fernandes MR; Ribeiro Júnior U; Nakano V; Avila-Campos MJ
    Braz J Microbiol; 2015; 46(4):1135-40. PubMed ID: 26691472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
    Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
    Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
    World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
    Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
    Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
    Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
    PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
    Repass J; Maherali N; Owen K; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26882501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.
    Engevik MA; Danhof HA; Auchtung J; Endres BT; Ruan W; Bassères E; Engevik AC; Wu Q; Nicholson M; Luna RA; Garey KW; Crawford SE; Estes MK; Lux R; Yacyshyn MB; Yacyshyn B; Savidge T; Britton RA; Versalovic J
    Gastroenterology; 2021 Mar; 160(4):1301-1314.e8. PubMed ID: 33227279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.
    Mehta RS; Nishihara R; Cao Y; Song M; Mima K; Qian ZR; Nowak JA; Kosumi K; Hamada T; Masugi Y; Bullman S; Drew DA; Kostic AD; Fung TT; Garrett WS; Huttenhower C; Wu K; Meyerhardt JA; Zhang X; Willett WC; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    JAMA Oncol; 2017 Jul; 3(7):921-927. PubMed ID: 28125762
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of
    Borowsky J; Haruki K; Lau MC; Dias Costa A; Väyrynen JP; Ugai T; Arima K; da Silva A; Felt KD; Zhao M; Gurjao C; Twombly TS; Fujiyoshi K; Väyrynen SA; Hamada T; Mima K; Bullman S; Harrison TA; Phipps AI; Peters U; Ng K; Meyerhardt JA; Song M; Giovannucci EL; Wu K; Zhang X; Freeman GJ; Huttenhower C; Garrett WS; Chan AT; Leggett BA; Whitehall VLJ; Walker N; Brown I; Bettington M; Nishihara R; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    Clin Cancer Res; 2021 May; 27(10):2816-2826. PubMed ID: 33632927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.